{"id":"W4408493853","doi":"10.25251/skin.10.supp.538","title":"Deucravacitinib in Psoriasis Patients with a History of Malignancy: Follow-up after 4 Years of Deucravacitinib Treatment in the POETYK PSO Program","year":2025,"lang":"en","type":"article","venue":"SKIN The Journal of Cutaneous Medicine","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"Probity Medical Research; Queen's University","funders":"Incyte; Pfizer; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Psoriasis; Malignancy; Medicine; Dermatology; Internal medicine","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009337381,0.0001394757,0.0005702964,0.0006120201,0.0005817261,0.0006998339,0.0002756928,0.0003368255,0.001046131],"category_scores_gemma":[0.001487005,0.0001925715,0.0007688466,0.0007970891,0.0001312734,0.0005306114,0.0003168293,0.0006982484,0.0002319189],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005505481,"about_ca_system_score_gemma":0.0005228501,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002947658,"about_ca_topic_score_gemma":0.004640346,"domain_scores_codex":[0.9994242,0.0001111897,0.00006464679,0.000160278,0.0001384112,0.000101214],"domain_scores_gemma":[0.9987581,0.000181514,0.0006423543,0.00006205747,0.0001395942,0.0002164445],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.003107378,0.0002217937,0.9825438,0.00004477082,0.0002222226,0.0001931947,0.00006954173,0.0001277895,0.000519286,0.00001966125,0.0004231124,0.01250752],"study_design_scores_gemma":[0.0001855605,0.001223076,0.9956912,0.00002344766,0.0002615844,0.0007311475,0.00009825885,0.0003577808,0.000305345,0.00003703424,0.001076334,0.000009168909],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9968454,0.00116467,0.0001307629,0.00005788062,0.00001049101,0.0000521313,0.0006509407,0.000007487227,0.001080178],"genre_scores_gemma":[0.9984156,0.0002716528,0.00007065701,0.00006237041,0.00001778052,0.00002501765,0.0008693862,0.000001676845,0.000265865],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002947658,"threshold_uncertainty_score":0.005860984,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.00954215173484367,"score_gpt":0.2347351296048634,"score_spread":0.2251929778700197,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}